|View printer-friendly version|
|Array BioPharma to Present at the Roth Capital Partners Annual Growth Stock Conference|
BOULDER, Colo., Feb. 8 /PRNewswire-FirstCall/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E. Conway, will speak at the Roth Capital Partners Annual Growth Stock Conference on February 22 in Dana Point, California. The public is welcome to participate in the conference through an audio webcast on the Array BioPharma website.
Event: Roth Capital Partners Annual Growth Stock Conference
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat life threatening and debilitating diseases. Our proprietary drug development pipeline is focused on the treatment of cancer and inflammatory disease and includes clinical candidates that are designed to regulate therapeutically important targets. In addition, leading pharmaceutical and biotechnology companies collaborate with Array to discover and develop drug candidates across a broad range of therapeutic areas. For more information on Array, please go to www.arraybiopharma.com.
SOURCE Array BioPharma Inc